v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenue:    
Total revenue $ 3,639 $ 4,262
Operating expenses:    
Research and development 44,198 50,429
Selling, general, and administrative 26,905 30,797
Goodwill impairment 20,950 181,432
Long-lived assets impairment 9,115 0
Total operating expenses 101,168 262,658
Loss from operations (97,529) (258,396)
Royalty liability interest expense - related parties (35,481) (34,190)
Other interest income, net 438 631
Non-operating income, net 400 9,271
Loss before income taxes (132,172) (282,684)
Income tax expense (29) (29)
Net loss (132,201) (282,713)
Net loss attributable to noncontrolling interest and redeemable noncontrolling interest (5,116) (31,325)
Net loss attributable to Cibus, Inc. stockholders $ (127,085) $ (251,388)
Basic net loss per share of Class A common stock (in dollars per share) $ (2.78) $ (10.83)
Diluted net loss per share of Class A common stock (in dollars per share) $ (2.78) $ (10.83)
Weighted average shares of Class A common stock outstanding - basic (in shares) 45,757,376 23,222,256
Weighted average shares of Class A common stock outstanding - diluted (in shares) 45,757,376 23,222,256